Henry I. Miller M.D.
Henry I. Miller M.D.
Home  |  Bio  |  Mobile Site  |  Follow @Twitter
Pundicity: Informed Opinion and Review

Latest Articles

Deception or Dementia? With Joe Biden, It's Likely Both.
A life-long habit of lying and rapid cognitive decline could make his presidential tenure a debacle.

April 16, 2021  •  Human Events

Joe Biden has benefited from the popular wisdom that he is a consensus builder, promoter of national unity, and an empathetic, straight-talking, working class guy from Scranton, Pennsylvania.

By all accounts, these are notions that should already have evaporated less than three months into his presidency. Bipartisanship has been nonexistent; his political stance has shifted far to the left; and his commission to study Supreme Court "reforms" appears to be a prelude to packing the court, a brazen power-grab. Nevertheless, the presidential speechwriters, flacks, and apparatchiks have obviously been instructed to emphasize Biden's supposed kinder, gentler, collaborative, truthful qualities at every opportunity.

Continue to the full article  |  More articles


'War against the West': Russia powers global vaccine rejectionist movement even as it inoculates its own citizens
Causing discord, economic damage, illness, and death in the U.S. is part of Russia's long-term strategy

April 15, 2021  •  Genetic Literacy Project

Anyone active on social media is aware that there is a great deal of passionate but ill-founded opposition to vaccination, including to the new COVID-19 vaccines. How could that be? Physicians and the public health establishment are constantly promoting vaccination, especially as we try to stem the tide of the coronavirus pandemic.

It turns out that the anti-vaccine sentiment is the product of what can only be described as an industry whose principal protagonists are an organized group of professional propagandists. As recently reported in the science journal Nature, they are people "running multi-million-dollar organizations, incorporated mainly in the USA, with as many as 60 staff each."

Continue to the full article  |  More articles


The FDA's 'Pause' on Distribution of the J&J Vaccine Is Overly Risk-Averse
Regulators opt to protect themselves instead of public health

April 14, 2021  •  Issues & Insights

Citing "an abundance of caution," the FDA on Tuesday recommended a "pause" in the administration of Johnson & Johnson's COVID-19 vaccine. The essence of that decision is that, as usual, federal regulators have put covering their derrieres above public health. Let me explain.

The decision was precipitated by six cases in the U.S. of a "rare and severe type of blood clot" in women between the ages of 18 and 48 who had received the vaccine. Almost seven million shots of the one-dose vaccine have been administered in the U.S., according to the FDA.

Continue to the full article  |  More articles


National Geographic's Pollution Of Scientific Discourse
The magazine cites bogus research, promotes anti-pesticide propaganda

April 12, 2021  •  Issues & Insights

For more than a century, National Geographic has produced a high-quality magazine that is well-grounded in science, history and culture. Lately, however, the editors have allowed agenda-driven articles based on flawed research to slip in between the covers.

Continue to the full article  |  More articles


Fund coronavirus research, not a climate change musical
Society doesn't owe a living to social scientists who perform shoddy, irrelevant, or worthless research

April 8, 2021  •  Washington Examiner

I've been a science nerd almost all my life. In graduate school, I was the co-discoverer of a bacterial enzyme essential to DNA replication and of a key enzyme in the influenza virus. I have written more than a thousand articles concerned with science and science policy. I'm convinced that America's prosperity is based on post-WWII preeminence in science and technology, much of it financed by federal funding.

Continue to the full article  |  More articles

home   |   biography   |   articles   |   mailing list   |   mobile site